CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Carla Vista Sober Living

Cactus Health Systems

Cactus Health Systems is a Guelph, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Empower ABA

Empower ABA is a company that provides Applied Behavior Analysis (ABA) therapy services for children with Autism Spectrum Disorder (ASD). Their mission is to empower families by providing the most effective ABA services to ensure that learners with aut...

ATS Health Services

ATS Health Services is a Jacksonville, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blue Cross Blue Shield of Michigan

Blue Cross Blue Shield of Michigan is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Detroit, MI. To find more information about Blue Cross Blue Shield of Michigan, please visit www.bcbsm.com